The Unified Hub brings together three of Germany’s most dynamic life science and innovation ecosystems: Bavaria (Bio^M), the Rhine-Neckar region (bioRN), and Berlin (ESMT). By combining regional strengths, networks, expertise and resources, the partners aim to create a nationally connected platform that helps innovators move more effectively from discovery to commercial success.

Germany is home to world-class research institutions, innovative start-ups, established biotechnology and pharmaceutical companies, and a growing community of investors and entrepreneurs. The Unified Hub plans to connect these strengths more closely across regions, creating greater opportunities for collaboration, technology translation, and venture growth.

The collaboration builds on the successful partnership between the three organizations in delivering entrepreneurial programs such as the Creative Destruction Lab (CDL)-Berlin Health Stream. Through the CDL-Berlin Health Stream, ambitious science-based ventures receive objective-driven mentorship from experienced entrepreneurs, operators, and investors to accelerate their commercial growth. Building on the strong foundation of CDL-Berlin that has been running since 2022, the Unified Hub will continue to support the CDL-Berlin Health Stream while expanding its portfolio with new initiatives that bridge the gap between scientific research and successful market adoption.

Through a coordinated national approach, the Unified Hub aims to:

• Accelerate the translation of scientific discoveries into market-ready healthcare solutions
• Connect innovators with mentors, investors, and industry partners across Germany
• Strengthen support for start-ups and emerging ventures at different stages of development
• Increase international visibility for Germany’s healthcare innovation ecosystem
• Foster greater collaboration between leading life science regions

The partners envision the Unified Hub as an open platform that complements existing regional activities and leverages national capabilities to create greater impact.

For researchers, founders, and industry partners, this means access to a broader network, more diverse expertise and expanded opportunities to engage with stakeholders across Germany’s healthcare innovation landscape.

As healthcare challenges become increasingly global, the Unified Hub will help position Germany as a connected and competitive environment for developing the next generation of therapeutics, diagnostics, medical technologies, and digital health solutions.

About Bio^M

Bio^M has been the network organization for the biotechnology industry in Munich and Bavaria for over 25 years on behalf of the Bavarian Ministry of Economic Affairs. Bio^M supports the Bavarian biotechnology and pharmaceutical industry with an extensive network for the initiation of new business contacts. The cluster management offers interested parties from Germany and abroad centralized access and a wide range of information about the industry. Bio^M provides comprehensive advice and special coaching, training and mentoring programs especially for prospective company founders. With its incubator MAxL (Munich Accelerator Life Sciences & Medicine), Bio^M also offers optimal conditions for pre-seed projects and early-stage start-ups in the biotech and healthtech sector. Bio^M has also been coordinating the m⁴ Award pre-seed competition in the field of biomedicine since 2011, which is funded by the Bavarian Ministry of Economic Affairs every other year with a total of 2.5 million Euros. In total, Bio^M has supported over 300 start-ups. In addition, Bio^M organizes a wide range of training courses, events and network meetings. More information at: www.bio-m.org/en

About bioRN

BioRN is the science and industry innovation cluster of the Rhine-Neckar region around Heidelberg, one of Germany’s strongest biotech and life-science hubs. It is a non-profit network fostering health innovations and serving its members by creating a rich translational ecosystem as well as promoting, representing and connecting the regional innovation stakeholders. BioRN has more than 185 institutional members, including the top academic and research institutions, 10 global pharmaceutical companies, a large range of small and medium-sized enterprises bolstering the life science ecosystem as well as local government organizations and representations of interests. With the vision “create innovation – foster translation”, bioRN has developed a clear strategy to become the leading life science cluster and to attract global investments and talent. Since its foundation in 1996, bioRN has been able to realise a large number of flagship projects in the region, including the establishment of Biolabs Heidelberg, one of the leading incubators for biotech and life science start-ups. Another flagship initiative is beLAB2122, a multi-year partnership between leading academic institutions in the Rhine-Main-Neckar region, as well as Evotec and BMS, aimed at accelerating the translation of research into clinical applications. Follow us on LinkedIn or visit our website.

About the DEEP Institute at ESMT Berlin

The Institute for Deep Tech Innovation (DEEP) at ESMT Berlin is dedicated to advancing deep-tech innovation by fostering dynamic ecosystems that accelerate technology transfer and the global scaling of startups. It identifies the best people, technologies, and business opportunities, brings them together in ways that translate these connections into globally succeeding ventures that advance Europe’s deep-tech leadership and competitiveness. Through strategic collaborations with research institutions, corporations, and investors, DEEP cultivates science-based innovations. By pioneering transformative initiatives, the institute empowers a new generation of deep-tech innovators to shape the technological future of Europe. DEEP Institute

Press contacts Bio^M
Bio^M Biotech Cluster Development GmbH
Gabriele Klingner, klingner@bio-m.org
Christiane Proll, proll@bio-m.org
+49 89 89 96 79 15 or
+49 178 5784263

Press contact bioRN
Stephanie Füller
sf@biorn.org
+49 151 17880177

Press contact ESMT Berlin
Molly Ihlbrock
martha.ihlbrock@esmt.org
+49 175 9390728